Aria Torkpour

机构：Hammersmith Hospital, Imperial College London

发表论文 16 篇 · 总被引 71 次 · h-index 3

代表论文

• Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events (2024 · Gut · 被引 43)
• Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data (2024 · Respiratory Research · 被引 16)
• Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab (2025 · Journal for ImmunoTherapy of Cancer · 被引 5)
• The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study (2026 · The Lancet Digital Health · 被引 3)
• A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 2)
• A Review on Artificial Intelligence as a Solution to Burnout in Interventional Radiology (2026 · CardioVascular and Interventional Radiology · 被引 1)